EN | TR
E-ISSN: 1307-5608
Evaluation of Liver Enzymes, Hemogram and Lipid Parameters in Acne Patients Using Systemic Isotretinoin
PDF
Cite
Share
Request
Research Article
VOLUME: 71 ISSUE: 2
P: 141-144
August 2018

Evaluation of Liver Enzymes, Hemogram and Lipid Parameters in Acne Patients Using Systemic Isotretinoin

J Ankara Univ Fac Med 2018;71(2):141-144
DOI: 10.4274/atfm.07108
Gül Aslıhan Çakır Akay 1
Dilsun Yıldırım 2
Fatma Gülru Erdoğan 1
Ayşe Bilgihan 3
1. Ufuk Üniversitesi Tıp Fakültesi, Dr. Rıdvan Ege Hastanesi, Deri ve Zührevi Hastalıkları Kliniği, Ankara, Türkiye
2. Şırnak Devlet Hastanesi, Dermatoloji Kliniği, Şırnak, Türkiye
3. Ufuk Üniversitesi Tıp Fakültesi, Dr. Rıdvan Ege Hastanesi, Biyokimya Kliniği, Ankara, Türkiye
No information available.
No information available
Received Date: 21.05.2018
Accepted Date: 25.07.2018
Publish Date: 10.10.2018
PDF
Cite
Share
Request

ABSTRACT

Objectives:

Systemic isotretinoin (SI) is the most effective agent in the treatment of resistant acne vulgaris, affecting all four pathogenetic factors. However, laboratory abnormalities caused by SI have been reported for many years. Current studies indicate that these disorders may be temporary transient changes, so that monthly monitoring of laboratory parameters is not required during routine SI therapy. In this study, it was aimed to evaluate changes in hemogram, lipid parameters and liver function tests in acne patients who received SI treatment.

Materials and Methods:

This study consisted of 52 patients (18-35 years old) diagnosed with severe, nodular acne that leaves scars and resistant to 4 months systematic antibiotics treatment. Patients received SI treatment with 0.5-1 mg/kg dose, in total 120-150 mg cumulative dose. Hemogram, liver enzyme and lipid parameters are recorded before treatment and 3- and 6-month visits.

Results:

When the results of before treatment, 3- and 6-month visits are statistically compared, a significant increase is observed in the values of gamma glutamyl transferase, total cholesterol, triglyceride, low density lipoprotein values and a significant decrease is observed in white sphere values.

Conclusion:

According to our study findings, the treatment of SI causes changes the white sphere, gamma glutamyl transferase, total cholesterol, triglyceride, low density lipoprotein levels. At the same time all these changes are within the normal reference value limits. Therefore, during treatment, instead of routine monthly observation, we propose a proper diet and a more intermittent follow-up.

Keywords: Acne, Isotretinoin, Hemogram Parameters

References

1
Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379:361-372.
2
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016;74:945-973.
3
Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf 2004;3:119-129.
4
McLane J, Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001;45:188-194.
5
Hansen TJ, Lucking S, Miller JJ, et al. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol 2016;72:323-328.
6
Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg 2008;27:197-206.
7
Bugdayci G. Polat M, Oguzman H, et al. Interpretation of biochemical tests using the refence change value in monitoring adverse efects of oral isotretinoin in 102 ethnic Turkish patients. Lab Med 2016;47:213-219.
8
Zane LT, Leyden WA, Marquelling AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016-1022.
9
Brezinski P, Borowska K, Chiriac A, et al. Adverse effects of isotretinoin: A large, retrospective review. Dernatol Ther 2017:30.
10
Karadağ AS, Çalka Ö, Akdeniz N. İzotretinoin kullanan 150 akne vulgaris hastasında yan etkilerin değerlendirilmesi. Turkderm 2011;45:37-42.
11
Kızılyel O, Metin MS, Elmas ÖF, et al. Effects of oral isotretinoin on lipids and liver enzymes in acne patients. Cutis 2014;94:234-238.
12
Ahmadvand H, Majdaldin A, Javanbakht A, et al. Effects of oral isotretinoin on serum lipids and gama glutamyl transpeptidase acitvitiy in acne vulgaris patients. Afr J Pharm Pharmacol 2011;5:1338-1341.
13
Pushpavalli G, Veeramani C, Pugalendi KV. Influence of chrysin on hepatic marker enzymes and lipid profile against D-galactosamine-induced hepatotoxicity rats. Food Chem Toxicol 2010;48:1654-1659.
14
Holt M, Ju C. Drug-induced liver injury. Handb Exp Pharmacol 2010;196:3-27.
15
Webster GF, Webster TG, Grimes LR. Laboratory tests in patients treated with isotretinoin: occurrence of liver and muscle abnormalities and failure of AST and ALT to predict liver abnormality. Dermatol Online J 2017:23.
16
Moeller KE, Touma SC. Prolonged tronmbocytopenia associated with isotretinoin. Ann Pharmacother 2003;37:1622-1624.
17
Karadag AS, Ertugrul DT, Takci Z. Isotretinoin modestly increases platelet count in acne patients. J Dermatol Treat 2013;24:139-140.
18
Yeşilova Y, Turan E, Şavik E, ve ark. Sistemik isotretinoin tedavisi alan orta ve şiddetli akne vulgarisli hastalarda hematolojik parametrelerin değerlendirilmesi. Harran Üniversitesi Tıp Fakültesi Dergisi 2014;11:98-101.
19
Ataseven A, Ugur Bilgin A. Effects of isotretinoin on the platelet counts and the mean platelet volume in patients with acne vulgaris. Scientific World Journal 2014;2014:156464.
20
Seçkin HY, Baş Y, Takcı Z, et al. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris. Cutan Ocul Toxicol 2016;35:89-91.
21
Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin? J Dermatolog Treat 2006;17:214-216.
22
Özuğuz P, Doğruk Kaçar S, Polat S, ve ark. İsotretinoin tedavisinin nötrofil/lenfosit oranı ve diğer hemogram parametreleri üzerine etkisinin değerlendirilmesi. Mustafa Kemal Üniv Tıp Derg 2013;4:9-14.
23
Gencoglan G, İnanır I, Miskioglu M, et al. Evaluation of sequential effect of isotretinoin on the hematological parameters in patients with acne vulgaris. Cutan Ocul Toxicol 2018;37:139-142.
24
Zane LT, Leyden WA, Marquelinf AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy acne vulgaris. Arch Dermatol 2006;142:1016-1022.
2024 ©️ Galenos Publishing House